Skip to main content
. 2022 Dec 26;11(1):59. doi: 10.3390/biomedicines11010059

Table 4.

Changes in sUA level in patients with gout after treatment with different urate-lowering drugs.

Type of ULT sUA Levels
Baseline After ULT Change in sUA
Allopurinol users, mg/dL 7.70 7.20 −0.65
Febuxostat users, mg/dL 7.91 6.45 −1.50
Benzbromarone users,
mg/dL
7.34 5.83 −1.64
p-Value 0.147 0.020 * 0.002 *

* p < 0.05. Values are the number of the variables ± standard deviation. Abbreviations: sUA, serum uric acid; ULT, urate-lowering therapy.